The Immune System, HIV, and Aging
Little more than a decade ago, it was almost inconceivable that the issue of aging with HIV infection would emerge as an important concern.
Better Late Than Never: Efavirenz Dose Optimization
After a study suggests that we’ve been using too high a dose of efavirenz for a decade and a half, the move toward scaling up a lower and more cost-effective one faces some hurdles By Tim Horn and Polly Clayden…
Marketplace Menaces: Discriminatory Practices by the ACA’s Qualified Health Plans
Advocates scramble to stay ahead of coverage rejections, formulary concerns, and exorbitant out-of-pocket expenses facing people living with HIV By Kenyon Farrow #GetCovered That’s the White House’s official hashtag and marketing campaign to spike the number of Americans enrolling into…
The White House’s Fuzzy Math
An Office of National AIDS Policy progress report obscures the state of the domestic U.S. HIV/AIDS response By Mark Harrington On World AIDS Day, December 1, 2013, the White House Office of National AIDS Policy (ONAP) issued a peppy and…
Forgotten Negatives: The Limits of Treatment as Prevention
The CDC’s High-Impact Prevention strategy takes aim at the stubborn HIV incidence rate in the United States. The only problem: it doesn’t include an ambitious plan for those at risk for the virus By Jeremiah Johnson There is no shortage…
Fool Us Once…
April 1. This is the day upon which we are reminded of what we are on the other three hundred and sixty-four. —Mark Twain, Pudd'nhead Wilson By Tim Horn We’re being duped by our government agencies. We’re being hoodwinked by…
TAGline Spring 2014
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS Spring 2014 The April Fools' Issue: April 1. This is the day upon which we are reminded of what we are on the other three hundred and sixty-four. —Mark…
Letter to Governor Cuomo on Ending AIDS in New York State
Follow-up to January 14, 2014 letter regarding the development of a plan to end AIDS in New York State.
Trials & Research Studies Listed in Clinicaltrials.gov
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH) A Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV (COPPEhR) Vaccine Immunity and Inflammation in the Aging Person Living With HIV…